Public-registry site landscape for NCT03254199, a Charcot-Marie-Tooth Disease study sponsored by Flex Pharma, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03254199 (registry record) |
| Sponsor | Flex Pharma, Inc. |
| Condition(s) | Charcot-Marie-Tooth Disease |
| Phase | PHASE2 |
| Listed sites | 20 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03254199 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →